Belmont Capital, LLC Merck & Co., Inc. Transaction History

Belmont Capital, LLC

$584 Million
Q3 2024

A detailed history of Belmont Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Belmont Capital, LLC holds 1,877 shares of MRK stock, worth $186,160. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,877

Previous 9,193 79.58%

Holding current value

$186,160

Previous $1.14 Million 81.28%

% of portfolio

0.04%

Previous 0.21%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$111.15 - $128.97 $813,173 - $943,544	-7,316 Reduced 79.58%	1,877 $213,000
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $232,372 - $249,565	1,877 Added 25.66%	9,193 $1.14 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $339,720 - $395,849	3,000 Added 69.51%	7,316 $965,000
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $426,065 - $463,662	4,253 Added 6750.79%	4,316 $470,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $102 - $114	1 Added 1.61%	63 $6,000
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $6,733 - $7,339	62 New	62 $7,000
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $162,016 - $181,609	-2,204 Reduced 25.23%	6,532 $536,000
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $146,947 - $173,088	-2,134 Reduced 19.63%	8,736 $673,000
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $78,947 - $87,615	-1,100 Reduced 9.19%	10,870 $889,000
Q1 2020 Apr 29, 2020	SELL	$63.36 - $87.82 $67,921 - $94,143	-1,072 Reduced 8.22%	11,970 $921,000
Q4 2019 Jan 14, 2020	BUY	$77.58 - $87.54 $1.01 Million - $1.14 Million	13,042 New	13,042 $1.19 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belmont Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belmont Capital, LLC with notifications on news.

Account

Belmont Capital, LLC Merck & Co., Inc. Transaction History